You may also like
CMS Announcement: Final Decision for use of PRP for Chronic Non-Healing Wounds
CMS covers autologous platelet-rich plasma (PRP) only for patients who have chronic non-healing diabetic, pressure, and/or venous wounds and when all the following conditions are met.
3 min read
Optimization of Leukocyte Concentration in Platelet-Rich Plasma for the Treatment of Tendinopathy
The optimum composition of PRP for the treatment of tendinopathy has not been directly investigated. Persistent inflammation results in inferior repair with scar tissue. The present study indicates that in an animal model, WBC in PRP contributes to inflammatory cytokine production. Therefore, leukocyte-reduced PRP may be the optimum preparation to stimulate superior healing without scar tissue formation.
1 min read
